Based on the proteomics methods, autoantibodies against α-enolase were considered potential biomarkers of NSCLC, and the combined detection of autoantibodies against α-enolase, carcinoembryonic antigen and cytokeratin 19 fragment could significantly improve the sensitivity of NSCLC diagnosis (39). Here, CEACAM5 is linked to non-small cell lung carcinoma.